Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids

Keyphrases

• Endothelial Cells 100%
• Biological Fluids 100%
• Complex Formation 100%
• Vascular Endothelial Growth Factor Receptor (VEGFR) 100%
• Vascular Endothelial Growth Factor 46%
• Flt-1 23%
• Soluble Receptor 15%
• Amniotic Fluid 15%
• High-affinity Receptor 7%
• Ligand Binding 7%
• Receptor Tyrosine Kinase 7%
• Gene Expression 7%
• Signal Transduction 7%
• Recombinant 7%
• Receptor-interacting Protein Kinase 1 (RIPK1) 7%
• Human Endothelial Cells 7%
• Alternative Splicing 7%
• Cell Culture 7%
• Angiogenesis 7%
• Vascular Disease 7%
• Membrane Receptors 7%
• Phorbol Ester 7%
• Mitogen 7%
• Hypoxia 7%
• Preeclampsia 7%
• Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) 7%
• Flk-1 7%
• Placental Growth Factor (PlGF) 7%
• Placenta 7%
• VEGF165 7%
• Intrauterine Growth Retardation 7%
• Human Melanoma Cells 7%
• Sink Function 7%

Biochemistry, Genetics and Molecular Biology

• Complex Formation 100%
• Vascular Endothelial Growth Factor A 100%
• Vascular Endothelial Growth Factor 60%
• PIGF 60%
• Amnion Fluid 40%
• Ligand Binding 20%
• Receptor Tyrosine Kinase 20%
• Messenger RNA 20%
• Gene Expression 20%
• Signal Transduction 20%
• Angiogenesis 20%
• Recombinant 20%
• Transmembrane Receptors 20%
• Kinase Insert Domain Receptor 20%
• Placental Growth Factor 20%
• Prenatal Growth 20%
• Eclampsia 20%

Immunology and Microbiology

• Complex Formation 100%
• Vasculotropin A 100%
• Vasculotropin 60%
• Amnion Fluid 40%
• ELISA 20%
• Gene Expression 20%
• Signal Transduction 20%
• Angiogenesis 20%
• Mitogen 20%
• Eclampsia 20%
• Receptor Affinity 20%
• Placental Growth Factor 20%
• Kinase Insert Domain Receptor 20%
• Placenta 20%
• Melanoma Cell Line 20%
• Prenatal Growth 20%
• Ligand Binding 20%
• Tyrosine 20%